United States US: Survival To Age 65: Male: % of Cohort data was reported at 81.615 % in 2016. This records an increase from the previous number of 81.372 % for 2015. United States US: Survival To Age 65: Male: % of Cohort data is updated yearly, averaging 73.582 % from Dec 1960 (Median) to 2016, with 57 observations. The data reached an all-time high of 81.615 % in 2016 and a record low of 63.787 % in 1967. United States US: Survival To Age 65: Male: % of Cohort data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Survival to age 65 refers to the percentage of a cohort of newborn infants that would survive to age 65, if subject to age specific mortality rates of the specified year.; ; United Nations Population Division. World Population Prospects: 2017 Revision.; Weighted average;

Mortality Statistics in US Cities

Deaths by Age and Cause of Death in 2016

By Health [source]

About this dataset

This dataset contains mortality statistics for 122 U.S. cities in 2016, providing detailed information about all deaths that occurred due to any cause, including pneumonia and influenza. The data is voluntarily reported from cities with populations of 100,000 or more, and it includes the place of death and the week during which the death certificate was filed. Data is provided broken down by age group and includes a flag indicating the reliability of each data set to help inform analysis. Each row also provides longitude and latitude information for each reporting area in order to make further analysis easier. These comprehensive mortality statistics are invaluable resources for tracking disease trends as well as making comparisons between different areas across the country in order to identify public health risks quickly and effectively

More Datasets

For more datasets, click here.

Featured Notebooks

• 🚨 Your notebook can be here! 🚨!

How to use the dataset

This dataset contains mortality rates for 122 U.S. cities in 2016, including deaths by age group and cause of death. The data can be used to study various trends in mortality and contribute to the understanding of how different diseases impact different age groups across the country.

In order to use the data, firstly one has to identify which variables they would like to use from this dataset. These include: reporting area; MMWR week; All causes by age greater than 65 years; All causes by age 45-64 years; All causes by age 25-44 years; All causes by age 1-24 years; All causes less than 1 year old; Pneumonia and Influenza total fatalities; Location (1 & 2); flag indicating reliability of data.

Once you have identified the variables that you are interested in,you will need to filter the dataset so that it only includes relevant information for your analysis or research purposes. For example, if you are looking at trends between different ages, then all you would need is information on those 3 specific cause groups (greater than 65, 45-64 and 25-44). You can do this using a selection tool that allows you to pick only certain columns from your data set or an excel filter tool if your data is stored as a csv file type .

Next step is preparing your data - it’s important for efficient analysis also helpful when there are too many variables/columns which can confuse our analysis process – eliminate unnecessary columns, rename column labels where needed etc ... In addition , make sure we clean up any missing values / outliers / incorrect entries before further investigation .Remember , outliers or corrupt entries may lead us into incorrect conclusions upon analyzing our set ! Once we complete the cleaning steps , now its safe enough transit into drawing insights !

The last step involves using statistical methods such as linear regression with multiple predictors or descriptive statistical measures such as mean/median etc ..to draw key insights based on analysis done so far and generate some actionable points !

With these steps taken care off , now its easier for anyone who decides dive into another project involving this particular dataset with added advantage formulated out of existing work done over our previous investigations!

Research Ideas

• Creating population health profiles for cities in the U.S.
• Tracking public health trends across different age groups
• Analyzing correlations between mortality and geographical locations

Acknowledgements

If you use this dataset in your research, please credit the original authors. Data Source

License

License: Dataset copyright by authors - You are free to: - Share - copy and redistribute the material in any medium or format for any purpose, even commercially. - Adapt - remix, transform, and build upon the material for any purpose, even commercially. - You must: - Give appropriate credit - Provide a link to the license, and indicate if changes were made. - ShareAlike - You must distribute your contributions under the same license as the original. - Keep intact - all notices that refer to this license, including copyright notices.

Columns

File: rows.csv | Column name | Description | |:--------------------------------------------|:-----------------------------------...

This table contains 2394 series, with data for years 1991 - 1991 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (1 items: Canada ...), Population group (19 items: Entire cohort; Income adequacy quintile 1 (lowest);Income adequacy quintile 2;Income adequacy quintile 3 ...), Age (14 items: At 25 years; At 30 years; At 40 years; At 35 years ...), Sex (3 items: Both sexes; Females; Males ...), Characteristics (3 items: Life expectancy; High 95% confidence interval; life expectancy; Low 95% confidence interval; life expectancy ...).

All cause of death rates by county, all races (includes Hispanic/Latino), both sexes, ages 65+, rural and urban, 2019-2023. Death data were provided by the National Vital Statistics System. Death rates (deaths per 100,000 population per year) are age-adjusted to the 2000 US standard population (20 age groups: <1, 1-4, 5-9, ... , 80-84, 85-89, 90+). Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by the National Cancer Institute. The US Population Data File is used for mortality data.

Number of deaths and mortality rates, by age group, sex, and place of residence, 1991 to most recent year.

This dataset documents cardiovascular disease (CVD) death rates, relative and absolute excess death rates, and trends. Specifically, this report presents county (or county equivalent) estimates of CVD death rates in 2000-2020, trends during 2010-2019, and relative and absolute excess death rates in 2020 by age group (ages 35–64 years, ages 65 years and older). All estimates were generated using a Bayesian spatiotemporal model and a smoothed over space, time, and 10-year age groups. Rates are age-standardized in 10-year age groups using the 2010 US population. Data source: National Vital Statistics System.

Rank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.

2018 2020, county-level U.S. heart disease death rates. Dataset developed by the Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention.Create maps of U.S. heart disease death rates by county. Data can be stratified by age, race/ethnicity, and sex.Visit the CDC/DHDSP Atlas of Heart Disease and Stroke for additional data and maps. Atlas of Heart Disease and StrokeData SourceMortality data were obtained from the National Vital Statistics System. Bridged-Race Postcensal Population Estimates were obtained from the National Center for Health Statistics. International Classification of Diseases, 10th Revision (ICD-10) codes: I00-I09, I11, I13, I20-I51; underlying cause of death.Data DictionaryData for counties with small populations are not displayed when a reliable rate could not be generated. These counties are represented in the data with values of '-1.' CDC/DHDSP excludes these values when classifying the data on a map, indicating those counties as 'Insufficient Data.'Data field names and descriptionsstcty_fips: state FIPS code + county FIPS codeOther fields use the following format: RRR_S_aaaa (e.g., API_M_35UP)  RRR: 3 digits represent race/ethnicity    All - Overall    AIA - American Indian and Alaska Native, non-Hispanic    API - Asian and Pacific Islander, non-Hispanic    BLK - Black, non-Hispanic    HIS - Hispanic    WHT - White, non-Hispanic  S: 1 digit represents sex    A - All    F - Female    M - Male  aaaa: 4 digits represent age. The first 2 digits are the lower bound for age and the last 2 digits are the upper bound for age. 'UP' indicates the data includes the maximum age available and 'LT' indicates ages less than the upper bound. Example: The column 'BLK_M_65UP' displays rates per 100,000 black men aged 65 years and older.MethodologyRates are calculated using a 3-year average and are age-standardized in 10-year age groups using the 2000 U.S. Standard Population. Rates are calculated and displayed per 100,000 population. Rates were spatially smoothed using a Local Empirical Bayes algorithm to stabilize risk by borrowing information from neighboring geographic areas, making estimates more statistically robust and stable for counties with small populations. Data for counties with small populations are coded as '-1' when a reliable rate could not be generated. County-level rates were generated when the following criteria were met over a 3-year time period within each of the filters (e.g., age, race, and sex).At least one of the following 3 criteria:At least 20 events occurred within the county and its adjacent neighbors.ORAt least 16 events occurred within the county.ORAt least 5,000 population years within the county.AND all 3 of the following criteria:At least 6 population years for each age group used for age adjustment if that age group had 1 or more event.The number of population years in an age group was greater than the number of events.At least 100 population years within the county.More Questions?Interactive Atlas of Heart Disease and StrokeData SourcesStatistical Methods

About this dataset

Context

The dataset tabulates the Dead Lake township population distribution across 18 age groups. It lists the population in each age group along with the percentage population relative of the total population for Dead Lake township. The dataset can be utilized to understand the population distribution of Dead Lake township by age. For example, using this dataset, we can identify the largest age group in Dead Lake township.

Key observations

The largest age group in Dead Lake Township, Minnesota was for the group of age 65-69 years with a population of 96 (15.02%), according to the 2021 American Community Survey. At the same time, the smallest age group in Dead Lake Township, Minnesota was the 25-29 years with a population of 7 (1.10%). Source: U.S. Census Bureau American Community Survey (ACS) 2017-2021 5-Year Estimates.

Content

When available, the data consists of estimates from the U.S. Census Bureau American Community Survey (ACS) 2017-2021 5-Year Estimates.

Age groups:

• Under 5 years
• 5 to 9 years
• 10 to 14 years
• 15 to 19 years
• 20 to 24 years
• 25 to 29 years
• 30 to 34 years
• 35 to 39 years
• 40 to 44 years
• 45 to 49 years
• 50 to 54 years
• 55 to 59 years
• 60 to 64 years
• 65 to 69 years
• 70 to 74 years
• 75 to 79 years
• 80 to 84 years
• 85 years and over

Variables / Data Columns

• Age Group: This column displays the age group in consideration
• Population: The population for the specific age group in the Dead Lake township is shown in this column.
• % of Total Population: This column displays the population of each age group as a proportion of Dead Lake township total population. Please note that the sum of all percentages may not equal one due to rounding of values.

Good to know

Margin of Error

Data in the dataset are based on the estimates and are subject to sampling variability and thus a margin of error. Neilsberg Research recommends using caution when presening these estimates in your research.

Custom data

If you do need custom data for any of your research project, report or presentation, you can contact our research staff at research@neilsberg.com for a feasibility of a custom tabulation on a fee-for-service basis.

Inspiration

Neilsberg Research Team curates, analyze and publishes demographics and economic data from a variety of public and proprietary sources, each of which often includes multiple surveys and programs. The large majority of Neilsberg Research aggregated datasets and insights is made available for free download at https://www.neilsberg.com/research/.

Recommended for further research

This dataset is a part of the main dataset for Dead Lake township Population by Age. You can refer the same here

2018 - 2020, county-level U.S. stroke death rates. Dataset developed by the Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention.Create maps of U.S. stroke death rates by county. Data can be stratified by age, race/ethnicity, and sex.Visit the CDC/DHDSP Atlas of Heart Disease and Stroke for additional data and maps. Atlas of Heart Disease and StrokeData SourceMortality data were obtained from the National Vital Statistics System. Bridged-Race Postcensal Population Estimates were obtained from the National Center for Health Statistics. International Classification of Diseases, 10th Revision (ICD-10) codes: I60-I69; underlying cause of death.Data DictionaryData for counties with small populations are not displayed when a reliable rate could not be generated. These counties are represented in the data with values of '-1.' CDC/DHDSP excludes these values when classifying the data on a map, indicating those counties as 'Insufficient Data.'Data field names and descriptionsstcty_fips: state FIPS code + county FIPS codeOther fields use the following format: RRR_S_aaaa (e.g., API_M_35UP)  RRR: 3 digits represent race/ethnicity    All - Overall    AIA - American Indian and Alaska Native, non-Hispanic    API - Asian and Pacific Islander, non-Hispanic    BLK - Black, non-Hispanic    HIS - Hispanic    WHT - White, non-Hispanic  S: 1 digit represents sex    A - All    F - Female    M - Male  aaaa: 4 digits represent age. The first 2 digits are the lower bound for age and the last 2 digits are the upper bound for age. 'UP' indicates the data includes the maximum age available and 'LT' indicates ages less than the upper bound. Example: The column 'BLK_M_65UP' displays rates per 100,000 black men aged 65 years and older.MethodologyRates are calculated using a 3-year average and are age-standardized in 10-year age groups using the 2000 U.S. Standard Population. Rates are calculated and displayed per 100,000 population. Rates were spatially smoothed using a Local Empirical Bayes algorithm to stabilize risk by borrowing information from neighboring geographic areas, making estimates more statistically robust and stable for counties with small populations. Data for counties with small populations are coded as '-1' when a reliable rate could not be generated. County-level rates were generated when the following criteria were met over a 3-year time period within each of the filters (e.g., age, race, and sex).At least one of the following 3 criteria:At least 20 events occurred within the county and its adjacent neighbors.ORAt least 16 events occurred within the county.ORAt least 5,000 population years within the county.AND all 3 of the following criteria:At least 6 population years for each age group used for age adjustment if that age group had 1 or more event.The number of population years in an age group was greater than the number of events.At least 100 population years within the county.More Questions?Interactive Atlas of Heart Disease and StrokeData SourcesStatistical Methods

2019 - 2021, county-level U.S. heart disease death rates. Dataset developed by the Centers for Disease Control and Prevention, Division for Heart Disease and Stroke Prevention.Data SourceMortality data were obtained from the National Vital Statistics System. Bridged-Race Postcensal Population Estimates were obtained from the National Center for Health Statistics. International Classification of Diseases, 10th Revision (ICD-10) codes: I00-I09, I11, I13, I20-I51; underlying cause of death.Data DictionaryData for counties with small populations are not displayed when a reliable rate could not be generated. These counties are represented in the data with values of '-1.' CDC excludes these values when classifying the data on a map, indicating those counties as 'Insufficient Data.'Data field names and descriptionsstcty_fips: state FIPS code + county FIPS codeOther fields use the following format: RRR_S_aaaa (e.g., API_M_35UP)  RRR: 3 digits represent race/ethnicity    All - Overall    AIA - American Indian and Alaska Native, non-Hispanic    ASN - Asian, non-Hispanic    BLK - Black, non-Hispanic    HIS - Hispanic NHP – Native Hawaiian or Other Pacific Islander, non-Hispanic MOR – More than one race, non-Hispanic    WHT - White, non-Hispanic  S: 1 digit represents sex    A - All    F - Female    M - Male  aaaa: 4 digits represent age. The first 2 digits are the lower bound for age and the last 2 digits are the upper bound for age. 'UP' indicates the data includes the maximum age available and 'LT' indicates ages less than the upper bound. Example: The column 'BLK_M_65UP' displays rates per 100,000 black men aged 65 years and older.MethodologyRates are calculated using a 3-year average and are age-standardized in 10-year age groups using the 2000 U.S. Standard Population. Rates are calculated and displayed per 100,000 population. Rates were spatially smoothed using a Local Empirical Bayes algorithm to stabilize risk by borrowing information from neighboring geographic areas, making estimates more statistically robust and stable for counties with small populations. Data for counties with small populations are coded as '-1' when a reliable rate could not be generated. County-level rates were generated when the following criteria were met over a 3-year time period within each of the filters (e.g., age, race, and sex).At least one of the following 3 criteria:At least 20 events occurred within the county and its adjacent neighbors.ORAt least 16 events occurred within the county.ORAt least 5,000 population years within the county.AND all 3 of the following criteria:At least 6 population years for each age group used for age adjustment if that age group had 1 or more event.The number of population years in an age group was greater than the number of events.At least 100 population years within the county.More Questions?Interactive Atlas of Heart Disease and StrokeData SourcesStatistical Methods

This dataset describes injury mortality in the United States beginning in 1999. Two concepts are included in the circumstances of an injury death: intent of injury and mechanism of injury. Intent of injury describes whether the injury was inflicted purposefully (intentional injury) and, if purposeful, whether the injury was self-inflicted (suicide or self-harm) or inflicted by another person (homicide). Injuries that were not purposefully inflicted are considered unintentional (accidental) injuries. Mechanism of injury describes the source of the energy transfer that resulted in physical or physiological harm to the body. Examples of mechanisms of injury include falls, motor vehicle traffic crashes, burns, poisonings, and drownings (1,2). Data are based on information from all resident death certificates filed in the 50 states and the District of Columbia. Age-adjusted death rates (per 100,000 standard population) are based on the 2000 U.S. standard population. Populations used for computing death rates for 2011–2015 are postcensal estimates based on the 2010 census, estimated as of July 1, 2010. Rates for census years are based on populations enumerated in the corresponding censuses. Rates for non-census years before 2010 are revised using updated intercensal population estimates and may differ from rates previously published. Causes of injury death are classified by the International Classification of Diseases, Tenth Revision (ICD–10). Categories of injury intent and injury mechanism generally follow the categories in the external-cause-of-injury mortality matrix (1,2). Cause-of-death statistics are based on the underlying cause of death. SOURCES CDC/NCHS, National Vital Statistics System, mortality data (see http://www.cdc.gov/nchs/deaths.htm); and CDC WONDER (see http://wonder.cdc.gov). REFERENCES National Center for Health Statistics. ICD–10: External cause of injury mortality matrix. National Center for Health Statistics. Vital statistics data available. Mortality multiple cause files. Hyattsville, MD: National Center for Health Statistics. Available from: https://www.cdc.gov/nchs/data_access/vitalstatsonline.htm. Murphy SL, Xu JQ, Kochanek KD, Curtin SC, and Arias E. Deaths: Final data for 2015. National vital statistics reports; vol 66. no. 6. Hyattsville, MD: National Center for Health Statistics. 2017. Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr66/nvsr66_06.pdf. Miniño AM, Anderson RN, Fingerhut LA, Boudreault MA, Warner M. Deaths: Injuries, 2002. National vital statistics reports; vol 54 no 10. Hyattsville, MD: National Center for Health Statistics. 2006.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138. Johnson AG, Linde L, Ali AR, et al. COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022. MMWR Morb Mortal Wkly Rep 2023;72:145–152. Johnson AG, Linde L, Payne AB, et al. Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months — 20 U.S. Jurisdictions, September 18, 2022–April 1, 2023. MMWR Morb Mortal Wkly Rep 2023;72:667–669.

This dataset includes count and age-adjusted rate per 100,000 population of mortality (death) in Virginia for 9 chronic conditions by year and by demographic groups (i.e., age, race/ethnicity, and sex). Age group values include 0 to 17 years, 18 to 44 years, 45 to 54 years, 55 to 64 years, 65 to 74 years, and 75+ years. Race/ethnicity values include American Indian or Alaska Native, Asian or Pacific Islander, Black or African American, Hispanic or Latino, and White. Sex values include female and male. Data set includes mortality data from 2016 to the most current year for Virginia residents.

The 9 chronic conditions include: Alzheimer’s Disease, Cardiovascular disease, Chronic Kidney Disease, Chronic Obstructive Pulmonary Disease, Asthma, Diabetes, Stroke, Heart Disease, and Hypertension. The International Classification of Diseases, Tenth Revision (ICD-10) codes are used to identify chronic disease mortality indicators. Definitions are based on Underlying Cause of Death on the death certificate outlined in the “Underlying Cause-of-Death List for Tabulating Mortality Statistics” instruction manual developed by the National Center for Health Statistics at the Centers for Disease Control and Prevention (CDC) found here OCR Document (cdc.gov).

This dataset documents rates and trends in heart disease and stroke mortality. Specifically, this report presents county (or county equivalent) estimates of heart disease and stroke death rates in 2000-2019 and trends during two intervals (2000-2010, 2010-2019) by age group (ages 35–64 years, ages 65 years and older), race/ethnicity (non-Hispanic American Indian/Alaska Native, non-Hispanic Asian/Pacific Islander, non-Hispanic Black, Hispanic, non-Hispanic White), and sex (women, men). The rates and trends were estimated using a Bayesian spatiotemporal model and a smoothed over space, time, and demographic group. Rates are age-standardized in 10-year age groups using the 2010 US population. Data source: National Vital Statistics System.

NOTE: This dataset has been retired and marked as historical-only. Weekly rates of COVID-19 cases, hospitalizations, and deaths among people living in Chicago by vaccination status and age. Rates for fully vaccinated and unvaccinated begin the week ending April 3, 2021 when COVID-19 vaccines became widely available in Chicago. Rates for boosted begin the week ending October 23, 2021 after booster shots were recommended by the Centers for Disease Control and Prevention (CDC) for adults 65+ years old and adults in certain populations and high risk occupational and institutional settings who received Pfizer or Moderna for their primary series or anyone who received the Johnson & Johnson vaccine. Chicago residency is based on home address, as reported in the Illinois Comprehensive Automated Immunization Registry Exchange (I-CARE) and Illinois National Electronic Disease Surveillance System (I-NEDSS). Outcomes: • Cases: People with a positive molecular (PCR) or antigen COVID-19 test result from an FDA-authorized COVID-19 test that was reported into I-NEDSS. A person can become re-infected with SARS-CoV-2 over time and so may be counted more than once in this dataset. Cases are counted by week the test specimen was collected. • Hospitalizations: COVID-19 cases who are hospitalized due to a documented COVID-19 related illness or who are admitted for any reason within 14 days of a positive SARS-CoV-2 test. Hospitalizations are counted by week of hospital admission. • Deaths: COVID-19 cases who died from COVID-19-related health complications as determined by vital records or a public health investigation. Deaths are counted by week of death. Vaccination status: • Fully vaccinated: Completion of primary series of a U.S. Food and Drug Administration (FDA)-authorized or approved COVID-19 vaccine at least 14 days prior to a positive test (with no other positive tests in the previous 45 days). • Boosted: Fully vaccinated with an additional or booster dose of any FDA-authorized or approved COVID-19 vaccine received at least 14 days prior to a positive test (with no other positive tests in the previous 45 days). • Unvaccinated: No evidence of having received a dose of an FDA-authorized or approved vaccine prior to a positive test. CLARIFYING NOTE: Those who started but did not complete all recommended doses of an FDA-authorized or approved vaccine prior to a positive test (i.e., partially vaccinated) are excluded from this dataset. Incidence rates for fully vaccinated but not boosted people (Vaccinated columns) are calculated as total fully vaccinated but not boosted with outcome divided by cumulative fully vaccinated but not boosted at the end of each week. Incidence rates for boosted (Boosted columns) are calculated as total boosted with outcome divided by cumulative boosted at the end of each week. Incidence rates for unvaccinated (Unvaccinated columns) are calculated as total unvaccinated with outcome divided by total population minus cumulative boosted, fully, and partially vaccinated at the end of each week. All rates are multiplied by 100,000. Incidence rate ratios (IRRs) are calculated by dividing the weekly incidence rates among unvaccinated people by those among fully vaccinated but not boosted and boosted people. Overall age-adjusted incidence rates and IRRs are standardized using the 2000 U.S. Census standard population. Population totals are from U.S. Census Bureau American Community Survey 1-year estimates for 2019. All data are provisional and subject to change. Information is updated as additional details are received and it is, in fact, very common for recent dates to be incomplete and to be updated as time goes on. This dataset reflects data known to CDPH at the time when the dataset is updated each week. Numbers in this dataset may differ from other public sources due to when data are reported and how City of Chicago boundaries are defined. For all datasets related to COVID-19, see https://data.cityofchic

IntroductionNontraumatic subarachnoid hemorrhage (ntSAH) often results from a ruptured aneurysm and correlates with significant morbidity and mortality, particularly among the older population. Despite its impact, limited comprehensive studies evaluate the longitudinal trends in ntSAH-related mortality in older adults in the United States (US).MethodsThe authors conducted a retrospective analysis using the CDC WONDER database from 1999 to 2020, analyzing Multiple Cause-of-Death Public Use death certificates to identify ntSAH as a contributing factor in the death of adults aged 65 years and older. We calculated age-adjusted mortality rates (AAMR) and annual percent change (APC) to examine trends across demographic variables such as sex, race/ethnicity, urbanization, and states/census region.ResultsA total of 78,260 ntSAH-related deaths (AAMR 8.50 per 100,000 individuals) occurred among older adults in the US from 1999 to 2020. The overall AAMR for ntSAH decreased from 9.98 in 1999 to 8.67 in 2020 with an APC of −0.7% [95% CI (−1.0, −0.3)]. However, the authors observed a noticeable rise from 2013 to 2020 with an APC of 1.7% [95% CI (0.8, 2.6)]. Sex, racial, and regional disparities were evident with higher mortality rates for ages 85 or greater (crude mortality rate 16.6), women (AAMR 9.55), non-Hispanic Asian or Pacific Islander (AAMR 12.5), and micropolitan areas (AAMR 8.99), and Western US (AAMR 8.65).ConclusionMortality from ntSAH increases with age, affects women disproportionately, and occurs more often in an inpatient setting. These findings necessitate targeted, multi-dimensional health policies and clinical interventions. Specialties beyond neurosurgery can utilize this data for improved risk stratification and early treatment. Policymakers should focus on equitable resource allocation and community-level interventions to mitigate these trends effectively.